Powder Fixed Combination With Antiseptic and Barrier Properties for Wound Management: Safety and Efficacy Aspects
DOI:
https://doi.org/10.20535/ibb.2020.4.3.211699Keywords:
Wounds treatment, Silver ions, Chlorhexidine, Hyaluronic acid, KaolinAbstract
Chronic wounds treatment is a huge problem for the health care of all countries both in the economic aspect (annual costs reach $ 9 billion) and in the time spent by medical personnel to organize adequate long-term monitoring of this category of patients. A variety of etiological, systemic, and local factors may be involved in the pathogenesis of a chronic wound. The situation is aggravated by the fact that with every year the resistance of microorganisms to the widest range of antibiotics is growing. The desire to reduce healthcare costs while improving outcomes drives search for new methods to replace traditional antibiotics. In recent decades, the effectiveness of the use of adsorbents of various nature, biopolymers, cationic surfactants, and various forms of silver for the treatment of wounds has been reassessed. The objective of this review is to summarize the accumulated data of clinical and preclinical studies of substances widely used in medical devices for wound healing: silver, chlorhexidine, hyaluronic acid, and kaolin. The search for alternative medicines for wound healing showed that the most encouraging results regarding multidirectional antimicrobial activity and high safety of use were shown by medicines based on silver, chlorhexidine, hyaluronic acid, and kaolin ions. Combinations of these compounds in one medical device allowed to achieve the optimal effect, which was confirmed by clinical trials of Kadermin (Kadefort).References
Wright JB, Lam K, Burrell RE. Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment. Am J Infect Control. 1998;26(6):572-7. DOI: 10.1053/ic.1998.v26.a93527
Lansdown ABG. Silver in health care: Antimicrobial effects and safety in use. Curr Probl Dermatol. 2006;33:17-34. DOI: 10.1159/000093928
Raymond JT. Is silver the ultimate antimicrobial bullet? Antibiotics (Basel). 2018;7(4):112. DOI: 10.3390/antibiotics7040112
Cutting K, White R, Edmonds M. The safety and efficacy of dressings with silver – addressing clinical concerns. Int Wound J. 2007;4(2):177-84. DOI: 10.1111/j.1742-481x.2007.00338.x
Linares HA, Fader RC. Evaluation of topical therapy with silver-kaolin (Argostop) in an experimental model of burn wound sepsis. Burns Incl Therm Inj. 1987;13(4):281-5. DOI: 10.1016/0305-4179(87)90046-5
Zieger MA, Ochoa M, Rahimi R, Campana G, Tholpady S, Ziaie B, et al. Skin regeneration using dermal substrates that contain autologous cells and silver nanoparticles to promote antibacterial activity: in vitro studies. Mil Med. 2017;182(S1):376-82. DOI: 10.7205/milmed-d-16-00133
Pavlík V, Sojka M, Mazúrová M, Velebný V. Dual role of iodine, silver, chlorhexidine and octenidine as antimicrobial and antiprotease agents. PLoS ONE. 2019;14(1):0211055. DOI: 10.1371/journal.pone.0211055
Gilbert P, Moore LE. Cationic antiseptics: diversity of action under a common epithet. J Appl Microbiol. 2005;99:703-15. DOI: 10.1111/j.1365-2672.2005.02664.x
Chen WYJ, Abatangelo G. Functions of hyaluronan in wound repair. Wound Rep Reg. 1999;7:79-89. DOI: 10.1046/j.1524-475x.1999.00079.x
Longinotti C. The use of hyaluronic acid based dressings to treat burns: A review. Burns Trauma. 2014;2(4):1-6. DOI: 10.4103/2321-3868.142398
Ferrari R, Boracchi P, Romussi S, Ravasio G, Stefanello D. Application of hyaluronic acid in the healing of non-experimental open wounds: A pilot study on 12 wounds in 10 client-owned dogs. Vet World. 2015;8(10):1247-59. DOI: 10.14202/vetworld.2015.1247-1259
Ulkür E, Oncul O, Karagoz H, Yeniz H. Comparison of silver-coated dressing (Acticoat (TM)), chlorhexidine acetate 0.5% (Bactigrass((R))), and fusidic acid 2% (Fucidin((R))) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds. Burns. 2005;31(7):874-7. DOI: 10.1016/j.burns.2005.05.002
Viseras C, Aguzzi C, Cerezo P, Lopez-Galindo A. Uses of clay minerals in semisolid health care and therapeutic products. Appl Clay Sci. 2007;36:37-50. DOI: 10.1016/j.clay.2006.07.006
Antimicrobial IV Dressings: Algidex AG® versus Chlorhexidine Gluconate [Internet]. Deroyal.com. 2020 [cited 2020 Aug 8]. Available from: https://www.deroyal.com/docs/default-source/product-literature/0-2426-algidex-vs-chlorhexidine-gluconate-white-paper-sept-2017.pdf?sfvrsn=7c5100b6_8
Cassino R, Ippolito AM. L'uso dell'argento ionico nella cura del piede diabetico:prevenzione e trattamento dell'infezione. Acta Biomed. 2013;84:3-9.
Hundeshagen G, Collins VN, Wurzer P, Sherman W, Voigt CD, Cambiaso-Daniel J, et al. A prospective, randomized, controlled trial comparing the outpatient treatment of pediatric and adult partial-thickness burns with suprathel or mepilex Ag. J Burn Care Res. 2018;39(2):261-7. DOI: 10.1097/bcr.0000000000000584
Morrison L, Zembower TD. Antimicrobial resistance. Gastrointest Endosc Clin N Am. 2020;30(4):619-35. DOI: 10.1016/j.giec.2020.06.004
Lansdown ABG. A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices. Adv Pharmacol Pharm Sci. 2010;2010:16. DOI: 10.1155/2010/910686
Mademli A. Osetreni inkontinenĉni dermatitidy u imobilnich pacientů. Lėĉbaran (CWMA). 2019:3:20-1.
Nikulnikov PI, Liksunov OV, Ratushniuk AV, Bicher AH. Possibilities of trophic ulcers treatment in patients with decompensated forms of chronic venous insufficiency of the lower extremities using KadefortTM spray. Zdorovia Ukrainy. 2019;1:1-2.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 The Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The ownership of copyright remains with the Authors.
Authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication and National Technical University of Ukraine “Igor Sikorsky Kyiv Polytechnic Institute” as the Publisher.
Authors are reminded that it is their responsibility to comply with copyright laws. It is essential to ensure that no part of the text or illustrations have appeared or are due to appear in other publications, without prior permission from the copyright holder.
IBB articles are published under Creative Commons licence:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under CC BY 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
